M Mine
Overview
Explore the profile of M Mine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leeme T, Mine M, Lechiile K, Mulenga F, Mosepele M, Mphoyakgosi T, et al.
HIV Med
. 2020 Sep;
22(1):1-10.
PMID: 32876378
Objectives: National guidelines in Botswana recommend baseline CD4 count measurement and both CD4 and HIV viral load (VL) monitoring post-antiretroviral therapy (ART) initiation. We evaluated the utility of CD4 count...
2.
Maurice P, Guilbaud L, Garel J, Mine M, Dugas A, Friszer S, et al.
Ultrasound Obstet Gynecol
. 2020 Jun;
57(5):783-789.
PMID: 32515830
Objective: To establish the prevalence of COL4A1 and COL4A2 gene mutations in fetuses presenting with a phenotype suggestive of cerebral injury. Methods: This was a single-center retrospective analysis of all...
3.
Rowley C, MacLeod I, Maruapula D, Lekoko B, Gaseitsiwe S, Mine M, et al.
J Antimicrob Chemother
. 2016 Mar;
71(5):1361-6.
PMID: 26929269
Objectives: The aim of the study was to evaluate for the presence of drug resistance to HIV medications in treatment-naive individuals in Botswana. Methods: Two different populations were evaluated for...
4.
Colin E, Sentilhes L, Sarfati A, Mine M, Guichet A, Ploton C, et al.
J Perinatol
. 2013 Dec;
34(1):75-7.
PMID: 24374867
The COL4A1 gene encodes the alpha1 chain of type IV collagen, a crucial component of nearly all basement membranes. Mutations in COL4A1 were first associated with cerebral microangiopathy and familial...
5.
Carra-Dalliere C, Ayrignac X, Renard D, Menjot de Champfleur N, Tourniaire P, Mine M, et al.
Cerebrovasc Dis
. 2013 Apr;
35(3):298-9.
PMID: 23595081
No abstract available.
6.
Imbard A, Boutron A, Vequaud C, Zater M, de Lonlay P, Ogier de Baulny H, et al.
Mol Genet Metab
. 2011 Sep;
104(4):507-16.
PMID: 21914562
Background: Pyruvate dehydrogenase complex (PDHc) deficiencies are an important cause of primary lactic acidosis. Most cases result from mutations in the X-linked gene for the pyruvate dehydrogenase E1α subunit (PDHA1)...
7.
Sadamori N, Yao E, Mine M, Tokunaga S, Matsunaga M, Nakamura H, et al.
Leuk Lymphoma
. 2011 Jan;
5(2-3):187-92.
PMID: 21269080
To assess parameters of therapeutic response and survival after the onset of the blastic phase (BP) in 47 patients with Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML), a number of...
8.
Rouaud T, Labauge P, Lasserve E, Mine M, Coustans M, Deburghgraeve V, et al.
Neurology
. 2010 Aug;
75(8):747-9.
PMID: 20733150
No abstract available.
9.
Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, et al.
Clin Exp Rheumatol
. 2008 Jan;
25(6):810-6.
PMID: 18173913
Objective: To evaluate the efficacy and safety of leukocytapheresis (LCAP) in patients with rheumatoid arthritis (RA) that is refractory to disease modifying antirheumatic drugs (DMARDs), we conducted a prospective, multicenter,...
10.
Nakamura H, Kawakami A, Ida H, Origuchi T, Matsuoka N, Tsuboi M, et al.
Scand J Rheumatol
. 2006 Jan;
34(6):489-90.
PMID: 16393775
No abstract available.